FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2968762282> ?p ?o ?g. }

• W2968762282 abstract "e14144 Background: Pharmacoeconomic studies deal with populations of patients as if they were admitted at the division of medical oncology in the same date. Real patients are treated along the entire year so that budget simulations should be adjusted to chronological patterns of oncological assistance. Deferred budget impact analysis is undergone in order to assess long-run economic implications of clinical decisions on first-line mCRC therapies in Spain. Methods: As metastatic colorectal cancer diagnosis is not affected by seasonal influences, we have created a mathematical model assuming that a single patient is diagnosed every month and this patient has a 53% possibility to harbor a native K-Ras sequence. Calculi were arranged based on median duration of therapy. For bevacizumab-based therapy, budget impact for year t+1 begins at month 5 and beyond. For patients that receive cetuximab-based therapy, budget impact for year t+1 begins at month 7. The same approach was performed for doublets without any monoclonal antibody. Prices for all drugs in Spain were assumed to represent the best-value for each drug including all possibilities to reduce pharmacy costs. For first line, median duration of therapy reported by randomized trials was used to calculate the final budget. 70kg and 1.7 m were used as reference for patient dose calculations. Results: When K-Ras status is not tested and bevacizumab-based schedules are administered to every patient, annual growth of budget increases by 55- 60%. If K-Ras status is analyzed and wild-type patients are treated with cetuximab combinations and mutated patients receive bevacizumab, yearly budget growth amounts to 39-41%. Annual budget growth is minimized (25%) when K-Ras wt patients are treated with cetuximab combinations whereas K-Ras mutated tumours received chemotherapy alone. Conclusions: Duration of therapy plays a key role on budget impact estimations from both overall and year to year perspectives. K-Ras based clinical decisions not only optimize outcomes as measured by response rates but also minimize economic implications on annual budget growths." @default.
• W2968762282 created "2019-08-22" @default.
• W2968762282 creator A5009978511 @default.
• W2968762282 creator A5010318754 @default.
• W2968762282 creator A5026127785 @default.
• W2968762282 creator A5028089976 @default.
• W2968762282 creator A5073300019 @default.
• W2968762282 creator A5077100656 @default.
• W2968762282 creator A5078163851 @default.
• W2968762282 date "2012-05-20" @default.
• W2968762282 modified "2023-10-18" @default.
• W2968762282 title "Year-to-year impact budget analysis of biologic therapies for first-line metastatic colorectal cancer (mCRC) therapy in Spain." @default.
• W2968762282 doi "https://doi.org/10.1200/jco.2012.30.15_suppl.e14144" @default.
• W2968762282 hasPublicationYear "2012" @default.
• W2968762282 type Work @default.
• W2968762282 sameAs 2968762282 @default.
• W2968762282 citedByCount "0" @default.
• W2968762282 crossrefType "journal-article" @default.
• W2968762282 hasAuthorship W2968762282A5009978511 @default.
• W2968762282 hasAuthorship W2968762282A5010318754 @default.
• W2968762282 hasAuthorship W2968762282A5026127785 @default.
• W2968762282 hasAuthorship W2968762282A5028089976 @default.
• W2968762282 hasAuthorship W2968762282A5073300019 @default.
• W2968762282 hasAuthorship W2968762282A5077100656 @default.
• W2968762282 hasAuthorship W2968762282A5078163851 @default.
• W2968762282 hasConcept C121608353 @default.
• W2968762282 hasConcept C126322002 @default.
• W2968762282 hasConcept C143998085 @default.
• W2968762282 hasConcept C2994076244 @default.
• W2968762282 hasConcept C526805850 @default.
• W2968762282 hasConcept C71924100 @default.
• W2968762282 hasConceptScore W2968762282C121608353 @default.
• W2968762282 hasConceptScore W2968762282C126322002 @default.
• W2968762282 hasConceptScore W2968762282C143998085 @default.
• W2968762282 hasConceptScore W2968762282C2994076244 @default.
• W2968762282 hasConceptScore W2968762282C526805850 @default.
• W2968762282 hasConceptScore W2968762282C71924100 @default.
• W2968762282 hasLocation W29687622821 @default.
• W2968762282 hasOpenAccess W2968762282 @default.
• W2968762282 hasPrimaryLocation W29687622821 @default.
• W2968762282 hasRelatedWork W1985611023 @default.
• W2968762282 hasRelatedWork W2002775374 @default.
• W2968762282 hasRelatedWork W2015860205 @default.
• W2968762282 hasRelatedWork W2164661093 @default.
• W2968762282 hasRelatedWork W2165180460 @default.
• W2968762282 hasRelatedWork W2255897075 @default.
• W2968762282 hasRelatedWork W2520145764 @default.
• W2968762282 hasRelatedWork W2546154929 @default.
• W2968762282 hasRelatedWork W2590280289 @default.
• W2968762282 hasRelatedWork W2590680924 @default.
• W2968762282 hasRelatedWork W2599979212 @default.
• W2968762282 hasRelatedWork W2760029312 @default.
• W2968762282 hasRelatedWork W2890631345 @default.
• W2968762282 hasRelatedWork W2964650870 @default.
• W2968762282 hasRelatedWork W2968298370 @default.
• W2968762282 hasRelatedWork W2978975558 @default.
• W2968762282 hasRelatedWork W2998019136 @default.
• W2968762282 hasRelatedWork W3002452840 @default.
• W2968762282 hasRelatedWork W3004481566 @default.
• W2968762282 hasRelatedWork W3095134455 @default.
• W2968762282 isParatext "false" @default.
• W2968762282 isRetracted "false" @default.
• W2968762282 magId "2968762282" @default.
• W2968762282 workType "article" @default.